DTX

Novamind Raises CA$10M, Heads Towards CSE Listing Toronto-based psychedelics company Novamind Ventures announced the closing of a private placement for CA$10 million ($7.6 million). Last week, the company confirmed that it successfully inked a definitive amalgamation agreement with Hinterland...

Psychedelics and biotech company ATAI Life Sciences announced Wednesday the launch of Viridia Life Sciences. This wholly-owned subsidiary will be dedicated to the study and production of the DMT molecule (N,N-Dimethyltryptamine). DMT is a psychoactive alkaloid present in Ayahuasca, a hallucinogenic...

Andrew Duplessie and Daniel Taylor, founders at AskTipster, a social media company, spoke with Benzinga about their aims to build out the DTX empowerment ecosystem, in addition to improving how people interact with stories.  Background Launched in 2015, the New York fintech started out as...